Edition:
United States

Daxor Corp (DXR.A)

DXR.A on American Stock Exchange

8.75USD
6 Dec 2016
Change (% chg)

-- (--)
Prev Close
$8.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,002
52-wk High
$9.80
52-wk Low
$7.25

DXR.A

Chart for DXR.A

About

Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The Company engages in the short selling of stock. The Company maintains a diversified securities portfolio, which consists primarily of the common and preferred stocks of electric utility companies. It has approximately 70... (more)
No analyst recommendations are available for DXR.A.

Overall

Beta: 0.12
Market Cap(Mil.): $33.63
Shares Outstanding(Mil.): 3.83
Dividend: 0.03
Yield (%): 0.34

Financials

  DXR.A Industry Sector
P/E (TTM): -- 57.76 30.40
EPS (TTM): -0.80 -- --
ROI: -14.58 7.10 15.24
ROE: -17.02 10.71 16.58

BRIEF-Daxor Corp appointed Michael Feldschuh as CEO

* On September 21, 2016 board appointed Michael Feldschuh as permanent president and CEO of co - SEC filing

Sep 23 2016

BRIEF-Daxor Corp announces hiring of chief financial officer

* Announces hiring of Eric Coleman as its new chief financial officer effective June 6, 2016

Jun 17 2016

Earnings vs. Estimates